Efficacy of topical ketorolac tromethamine 0.4% for control of pain or discomfort associated with cataract surgery

References

• Jett MF, Ramesha CS, Brown CD, et al. Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat. J Pharmacol Exp Ther 1999;288:1288–97
   PubMed Web of Science ®Google Scholar
• Seitz B, Sorken K, LaBree LD, Garbus JJ, McDonnell PJ. Corneal sensitivity and burning sensation. Comparing topical ketorolac and diclofenac. Arch Ophthalmol 1996;114:921–4
   Google Scholar
• Sun R, Gimbel HV. Effects of topical ketorolac and diclofenac on normal corneal sensation. J Refract Surg 1997;13:158–61
   PubMed Web of Science ®Google Scholar
• Narvaez J, Kroll P, Guzek JP. Effect of topical diclofenac and ketorolac on patient discomfort and corneal sensitivity. J Refract Surg 2002;18:145–8
   Google Scholar
• Heier J, Cheetham JK, Degryse R, et al. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial. Am J Ophthalmol 1999;127: 253–9
   Google Scholar
• Solomon KD, Cheetham JK, DeGryse R, Brint SF, Rosenthal A. Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery. Ophthalmology 2001;108: 331–7
   Google Scholar
• el-Harazi SM, Ruiz RS, Feldman RM, Villanueva G, Chuang AZ. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells. Ophthalmic Surg Lasers 1998;29: 539–44
   Google Scholar
• Flach AJ, Lavelle CJ, Olander KW, Retzlaff JA, Sorenson LW. The effect of ketorolac tromethamine solution 0.5% in reducing postoperative inflammation after cataract extraction and intraocular lens implantation. Ophthalmology 1988;95: 1279–84
   Google Scholar
• Holzer MP, Solomon KD, Sandoval HP, Vroman DT. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: prospective randomized double-masked study. J Cataract Refract Surg 2002;28: 93–9
   Google Scholar
• Ostrov CS, Sirkin SR, Deutsch WE, Masi RJ, Chandler JW, Lindquist TD. Ketorolac, prednisolone, and dexamethasone for postoperative inflammation. Clin Ther 1997;19:259–72
   PubMed Web of Science ®Google Scholar
• Simone JN, Pendelton RA, Jenkins JE. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery. J Cataract Refract Surg 1999;25: 699–704
   Google Scholar
• Solomon KD, Vroman DT, Barker D, Gehlken J. Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Prospective randomized double-masked study. J Cataract Refract Surg 2001;27:1232–7
   Google Scholar
• Brint SF, Cheetham JK, DeGryse R, Abel ML, Thompson VM, Rosenthal A. Efficacy and safety of nonpreserved ketorolac ophthalmic solution in postoperative ocular pain following radial keratotomy. J Cataract Refract Surg 1999;25:41–9
   PubMed Web of Science ®Google Scholar
• McDonald MB, Brint SF, Caplan DI, Bourque LB, Shoaf K. Comparison of ketorolac tromethamine, diclofenac sodium, and moist drops for ocular pain after radial keratotomy. J Cataract Refract Surg 1999;25:1097–108
   Google Scholar
• Birt CM. The use of topical ketorolac 0.5% for pain relief following cyclophotocoagulation. Ophthalmic Surg Lasers Imaging 2003;34:381–5
   PubMed Web of Science ®Google Scholar
• Price Jr FW, Price MO, Zeh W, Dobbins K. Pain reduction after laser in situ keratomileusis with ketorolac tromethamine ophthalmic solution 0.5%: a randomized, double-masked, placebo-controlled trial. J Refract Surg 2002;18: 140–4
   Google Scholar
• Goyal R, Shankar J, Fone DL, Hughes DS. Randomised controlled trial of ketorolac in the management of corneal abrasions. Acta Ophthalmol Scand 2001;79:177–9
   PubMedGoogle Scholar
• Kaiser PK, Pineda R 2nd. A study of topical nonsteroidal anti-inflammatory drops and no pressure patching in the treatment of corneal abrasions [Corneal Abrasion Patching Study Group]. Ophthalmology 1997;104:1353–9
   Google Scholar
• Kitazawa Y. Increased intraocular pressure induced by corticosteroids. Am J Ophthalmol 1976;82:492–5
   PubMed Web of Science ®Google Scholar
• Kolker AE, Stewart RM, Alton E, LeMon L. Dexamethasone testing in prison inmates. Invest Ophthalmol 1971; 10:198–202
   PubMedGoogle Scholar
• Halpern MT, Palmer CS, Foster S, Pal A, Battista C. A pharmacoeconomic analysis of rimexolone for the treatment of ophthalmic inflammatory conditions. Am J Manag Care 1998;4:854–62
   Google Scholar
• Nagy ZZ, Szabo A, Krueger RR, Suveges I. Treatment of intraocular pressure elevation after photorefractive keratectomy. J Cataract Refract Surg 2001;27:1018–24
   PubMed Web of Science ®Google Scholar
• Barba KR, Samy A, Lai C, Perlman JI, Bouchard CS. Effect of topical anti-inflammatory drugs on corneal and limbal wound healing. J Cataract Refract Surg 2000;26:893–7
   PubMed Web of Science ®Google Scholar
• McCarey BE, Napalkov JA, Pippen PA, Koester JM, Reaves T. Corneal wound healing strength with topical antiinflammatory drugs. Cornea 1995;14:290–4
   Google Scholar
• Fraser-Smith EB, Matthews TR. Effect of ketorolac on Pseudomonas aeruginosa ocular infection in rabbits. J Ocul Pharmacol 1988;4: 101–9
   PubMed Web of Science ®Google Scholar
• Solomon KD, Donnenfeld ED, Raizman MD, et al.; Ketorolac Reformulation Study Groups 1 and 2. Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients. J Cataract Refract Surg 2004;30: 1653–560
   Google Scholar